Article

Silicone hydrogel daily disposable contact available

A new silicone hydrogel daily disposable contact lens (1-Day Acuvue TruEye, Vistakon) is now available in the United States, after having been cleared by the FDA in June.

Orlando, FL-A new silicone hydrogel daily disposable contact lens (1-Day Acuvue TruEye, Vistakon) is now available in the United States, after having been cleared by the FDA in June.

It is the first and only such contact lens available in the United States, according to the manufacturer.

The contact lens combines narafilcon B, which is a silicone hydrogel material, and proprietary technology (Hydraclear 1). It also offers the highest level of ultraviolet radiation protection in a contact lens, according to the company.

An ongoing 1-year, 94-subject, randomized, investigator-masked, parallel-group study compared eyes of patients wearing the new contact lens with eyes of patients who never have worn contact lenses. After the contact lens-wearing patients had worn the silicone hydrogel daily disposable lenses for 1 month, the contact lens was shown to have no significant effect on the ocular surface of the patients’ eyes compared with the ocular surface of the eyes of the non-contact lens wearers across five of six contact lens-related measures associated with eye health. In addition, the new contact lens was shown to provide high levels of comfort from morning to night, comparable with wearing no contact lens, according to the company.

“The data suggest that [the lens] can help maintain ocular health with the near ‘no-lens’ experience and keep the lens-wearing eye looking white and healthy, while also providing consistent comfort throughout the day,” said Colleen Riley, OD, MS, FAAO, vice president of professional development at Vistakon.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.